Quiz
Quiz: Overall Survival in Patients With Prostate Cancer Receiving Enzalutamide or Abiraterone
01/27/2022
Current Issue
October 2024
Volume 10
Issue 5
Subscribe
Journal of Clinical Pathways Newsletter